Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced poster presentations at the ...

Highlights from Prelude’s efforts to discover and develop selective KAT6A degraders, including preclinical data, demonstrating potential for a differentiated efficacy and safety profile ...

A paper goods supplier that produces private label products for retailers like Aldi ... a Phoenix, Arizona-based company announced the move earlier this month, listing assets and liabilities ...

We recently published a list of the 15 Low Profile Dividend Champions to Buy. In this article, we are going to take a look at where Sonoco Products Company (NYSE:SON) stands against other low ...

Well-known baby product maker Gerber Products Company issued a recall reminder in tandem with the Food and Drug Administration (FDA) on April 18 after affected products were still seen on store ...

To enquire about specific property features for 77 Presentation Boulevard, Winter Valley, contact the agent. What is the size of the property at 77 Presentation Boulevard, Winter Valley?

08:00 - Presentation will be held only via live webcast and earnings call. The presentation will be hosted by Mats Hovland Vikse, CEO, Paul Harrison, CFO and Parth Joshi, CPO. The presentation will be ...

The study, which showed that hydrocelin is non-pyrogenic, was part of a series of preclinical tests into several safety aspects for the product, all of which have yielded a satisfactory profile ...

It is the largest contract the company has received and the first time ... A few weeks ago Deployed scored another high-profile ICE hire: Marlen Pineiro joined Deployed after 40 years in ...

Member states of the European Union (E.U.) have agreed to tariffs on a range of U.S. products in response to President Trump’s sweeping new import taxes. EU states voted Wednesday to ...

Haitian’s distribution network and its strong negotiation power over channel partners could allow the company to transition its product portfolio and scale when market demand changes.